From the BBY website
BBY Analyst Dr Dennis Hulme has published research today on Pharmaxis, a company that he has as a STRONG BUY. If you would like a copy of Dr Hulme's work, please contact your BBY Adviser. With a target price of $1.80, that's terrific upside from a current share price of $1.07.
Does anyone have a copy of this ressearch I am not a client of BBY so cannot get access .
